Qube Research & Technologies (QRT)
MRK icon

Qube Research & Technologies (QRT)’s Merck MRK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8M Sell
371,600
-66,500
-15% -$7.78M 0.04% 510
2026
Q1 		$52.7M Sell
438,100
-369,900
-46% -$42.7M 0.06% 407
2025
Q4 		$85.1M Sell
808,000
-391,700
-33% -$36.8M 0.09% 301
2025
Q3 		$101M Sell
1,199,700
-12,900
-1% -$1.06M 0.1% 239
2025
Q2 		$96M Buy
1,212,600
+171,600
+16% +$13.6M 0.1% 264
2025
Q1 		$93.4M Buy
1,041,000
+659,100
+173% +$61.5M 0.11% 237
2024
Q4 		$38M Sell
381,900
-26,500
-6% -$2.73M 0.05% 478
2024
Q3 		$46.4M Buy
408,400
+334,200
+450% +$39.7M 0.07% 369
2024
Q2 		$9.19M Sell
74,200
-52,500
-41% -$6.76M 0.01% 957
2024
Q1 		$16.7M Sell
126,700
-161,200
-56% -$19.9M 0.03% 630
2023
Q4 		$31.4M Buy
287,900
+60,900
+27% +$6.32M 0.06% 389
2023
Q3 		$23.4M Buy
227,000
+147,100
+184% +$15.9M 0.06% 369
2023
Q2 		$9.22M Buy
+79,900
New +$9.07M 0.03% 556

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Merck (MRK) in Q2 2026: 1,044,210 shares worth $134M. The stake represents 0.12% of the portfolio and ranks #204 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRK as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in MRK in Q1 2018 and has held it in 27 quarters since. The position peaked at $529M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,044,210 shares of Merck worth $134M as of Q2 2026.
  • Merck was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Merck made up 0.12% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #204 holding.
  • Qube Research & Technologies (QRT) first reported a position in Merck in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Merck position peaked at $529M in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.